Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BriaCell Therapeutics Corp. - Common Shares (NQ:BCTX)

7.080 -0.090 (-1.26%)
Streaming Delayed Price Updated: 10:11 AM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BriaCell Therapeutics Corp. - Common Shares

< Previous 1 2 3 4 Next >
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Here are the top movers in Wednesday's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
News headline image
Why BriaCell Therapeutics (BCTX) Stock Is Down 40% ↗
BriaCell Therapeutics shares are trading lower by 40% Thursday afternoon. The company announced the pricing of a $5.5 million public offering. 
Via Benzinga
News headline image
BriaCell: An Emerging Immuno - Oncology Company ↗
BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer. 
Via Talk Markets
New Treatments May Help Those With Advanced Breast Cancer Live Longer
Via StatePoint Media
News headline image
Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Another BriaCell Therapeutics Goal: A Better Treatment For Prostate Cancer ↗
A look at BriaCell's research into a better treatment for prostate cancer. 
Via Talk Markets
News headline image
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase ↗
 
Via Benzinga
News headline image
Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge ↗
 
Via Benzinga
News headline image
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday ↗
BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint inhibitor. 
Via Benzinga
News headline image
Dow Tumbles 350 Points; US Inflation Rate Slows In August ↗
 
Via Benzinga
Topics Economy Stocks
News headline image
BCTX Stock Earnings: BriaCell Therapeutics Beats EPS for Q3 2024 ↗
BCTX stock results show that BriaCell Therapeutics beat analyst estimates for earnings per share the third quarter of 2024. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are a hot topic as investors return to trading on Tuesday following the long holiday weekend! 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Pre-market stock movers are worth checking out as we have all of the hottest market news available on Tuesday morning! 
Via InvestorPlace
News headline image
BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 ↗
BriaCell Therapeutics just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
Get Rich Quick With These 3 Penny Stocks to Buy Now ↗
Our economy has and will continue to show strength and resilience, you should invest in these three penny stocks to buy quick. 
Via InvestorPlace
Topics Economy
News headline image
BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients ↗
BriaCell Therapeutics Corp (NASDAQ: BCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients... 
Via Benzinga
Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food... 
Via FinancialNewsMedia
News headline image
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
CEO, William V. Williams, Reveals Game-Changing Partnership and Innovative Breakthroughs in Targeted Immunotherapies for Cancer Treatment 
Via TheNewswire.com
News headline image
BriaCell Therapeutics Corp. CEO is Featured in an Interview With SmallCapsDaily
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs... 
Via FinancialNewsMedia
News headline image
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers ↗
From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock... 
Via Talk Markets
News headline image
BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer ↗
Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach. 
Via Talk Markets
News headline image
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
By Ernest Dela Aglanu, Benzinga 
Via News Direct
Topics Death
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX) are ramping up efforts to help reduce or eliminate the growing... 
Via TheNewswire.com
Topics Death
News headline image
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients ↗
Small and big pharma companies such as Pfizer Inc. (NYSE: PFE), Celldex Therapeutics Inc. (NASDAQ: CLDX), and Hologic Inc. (NASDAQ: HOLX< 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.